1. Home
  2. CPS vs MRVI Comparison

CPS vs MRVI Comparison

Compare CPS & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cooper-Standard Holdings Inc.

CPS

Cooper-Standard Holdings Inc.

N/A

Current Price

$32.14

Market Cap

631.2M

ML Signal

N/A

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

N/A

Current Price

$3.49

Market Cap

472.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPS
MRVI
Founded
1960
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
631.2M
472.8M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
CPS
MRVI
Price
$32.14
$3.49
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$43.33
$4.57
AVG Volume (30 Days)
263.5K
1.1M
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
94.87
14.29
EPS
N/A
N/A
Revenue
N/A
$185,743,000.00
Revenue This Year
$4.42
$11.80
Revenue Next Year
$6.36
$7.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.38
$1.67
52 Week High
$47.98
$4.11

Technical Indicators

Market Signals
Indicator
CPS
MRVI
Relative Strength Index (RSI) 38.49 52.07
Support Level $30.64 $3.25
Resistance Level $35.13 $3.65
Average True Range (ATR) 1.43 0.19
MACD -1.03 0.04
Stochastic Oscillator 16.55 58.74

Price Performance

Historical Comparison
CPS
MRVI

About CPS Cooper-Standard Holdings Inc.

Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: